Illumina Inc. (ILMN) Dividend Safety Gauge & 10-Year DRIP Compounder

Per the Roarable RQD rating, ILMN scores 77 out of 100, grade B+, labeled "Roarable Buy — Very Good Cash & Smart-Money Inflow." The five pillars are:

• Fundamental Cash Engine: 18 / 20. Per the Roarable RQD rating, this reflects ROIC of 18.2% and an FCF yield of 2.13%. For a prospective investor, this is the strongest operating-quality signal in the rating, indicating the business is generating returns above a typical cost of capital. The low FCF yield, however, means the market is pricing in substantial future growth; investors are paying a high multiple for current cash generation.
• Whale 13F Flow: 19 / 20. Per the Roarable RQD rating, this pillar captures institutional accumulation and options positioning. It is the highest-scoring pillar and suggests large holders have been adding exposure. Investors should note that 13F data in this dossier is not itemized in the source data (see Analyst View), so this score cannot be traced to specific filers here.
• Insider Conviction: 12 / 20. Per the Roarable RQD rating, this reflects SEC Form 4 and Congressional PTR cluster flow. A mid-range score indicates insider activity is present but not decisively one-directional.
• Macro Regime Fit: 13 / 20. Per the Roarable RQD rating, beta is 1.16 and the score reflects sector sensitivity. A beta above 1.0 implies the stock has historically moved more than the market; in a risk-off environment, drawdowns could be amplified.
• Forensic Balance Sheet: 15 / 20. Per the Roarable RQD rating, Altman Z is 9.52, Piotroski F is 8/9, and Debt/Equity is 0.49. These readings point to a financially sound balance sheet with low distress risk and strong internal fundamentals.

Valuation tradeoff: per the market data, P/E (TTM) is 51.5 and EV/EBITDA is 47.5. Upside depends on sustained earnings expansion; if growth slows, the multiple leaves limited margin for error. The stock's position within its 52-week range of $112.65 to $309.35 (price $290.06) means it trades near the upper end of that band.

Per the recent news wire (all items flagged YELLOW, impact label MARKET WIRE):

• A Yahoo Finance report headlined "Illumina (ILMN) Shares Skyrocket, What You Need To Know" appeared about one hour before the data timestamp.
• An Investor's Business Daily item, "Illumina Crashes As Tariffs, AI Woes Eat Into 157% Run-Up," cites tariffs and AI concerns as pressures after a large run-up. This is a risk watch item.
• A Yahoo Finance item references the sequencing business recovering and asks whether the stock is ahead of itself, a valuation risk flag.
• A Yahoo Finance item references a genomics AI launch and suggests the stock may be near fair value, a neutral-to-cautious flag.
• A Trefis item compares ILMN to Thermo Fisher, a relative-valuation reference.

Proprietary signals: Per the Butterfly Supply-Chain Graph, no proprietary signals are recorded.

• What are the reported cash and EPS figures for FY 2023 through FY 2025, since the financials list them as N/A?
• Which institutional 13F filers drove the Whale pillar score of 19/20, and what is the scale of that accumulation?
• What specific tariff exposure and AI-related risks did the Investor's Business Daily report describe, and how do they map to reported margins?
• What drove the swing from FY 2024 and FY 2023 operating losses to FY 2025 operating income of $807.0M?
• What analyst consensus, price targets, and insider transactions exist, given that analyst and holder data are unavailable?